From left to right: Neuranics’s chief technology officer (CTO) Hadi Heidari with CEO Noel McKenna and chief strategy officer (CSO) Kia Nazarpour. Credit: © Neuranics 2025.

从左到右：Neuranics的首席技术官（CTO）哈迪·海达里与首席执行官（CEO）诺埃尔·麦肯纳和首席战略官（CSO）基亚·纳扎普尔。图片来源：© Neuranics 2025。

Scotland-based Neuranics has secured $8m in seed funding to expedite the growth and commercial adoption of the tunnelling magnetoresistance (TMR) magnetic sensing technology.

总部位于苏格兰的Neuranics公司已获得800万美元的种子资金，以加速隧道磁阻（TMR）磁传感技术的增长和商业应用。

Blackfinch Ventures spearheaded the funding round, with contributions from Archangels and ongoing support from the University of Glasgow, Par Equity, and Old College Capital, the venture investment fund of the University of Edinburgh.

Blackfinch Ventures领投了本轮投资，Archangels参与投资，格拉斯哥大学、Par Equity和爱丁堡大学的风险投资基金Old College Capital继续提供支持。

Go deeper with GlobalData

深入挖掘GlobalData

Reports

报告

Artificial Intelligence in Healthcare: Non-Invasive Physiological M...

医疗保健中的人工智能：非侵入性生理学...

Reports

报告

Artificial Intelligence in Medical Devices: AI Assisted NMR Spectro...

医疗设备中的人工智能：AI辅助的核磁共振波谱...

Data Insights

数据洞察

The gold standard of business intelligence.

商业智能的黄金标准。

Find out more

了解更多

These funds are earmarked for the company’s next growth phase, which includes bolstering the team, innovation, and the TMR technology integration into various high-tech markets, particularly in wearables, extended reality (XR), and digital health sectors.

这些资金将用于公司的下一个增长阶段，其中包括壮大团队、创新以及将TMR技术集成到各种高科技市场，特别是在可穿戴设备、扩展现实（XR）和数字健康领域。

Neuranics noted that its sensors are low-power, scalable, ultra-sensitive and capable of identifying minuscule magnetic signals from the human body.

Neuranics指出，其传感器具有低功耗、可扩展、超灵敏的特点，能够识别人体发出的微小磁信号。

These sensors allow for muscle activity tracking for gesture identification and monitoring heart signals without the need for skin contact.

这些传感器可以实现肌肉活动跟踪，用于手势识别和心电信号监测，且无需与皮肤接触。

The technology offers improvements over traditional methods in terms of accuracy, power efficiency, and the potential for continuous monitoring.

该技术在准确性、功率效率以及持续监控的潜力方面比传统方法有所改进。

With this latest capital injection, the company is set to improve its technology and solidify partnerships with the global XR and semiconductor industries.

通过这笔最新的资本注入，该公司将改进其技术，并巩固与全球 XR 和半导体行业的合作伙伴关系。

Neuranics was founded in 2021 as the first joint spinout of the University of Glasgow and the University of Edinburgh.

Neuranics 于2021年成立，是格拉斯哥大学和爱丁堡大学的第一个联合分拆公司。

Neuranics CEO Noel McKenna said: “This investment marks a significant step forward as we continue pioneering new applications for magnetic sensing. With the support of our investors, we are expanding our team, advancing our technology, and bringing our solutions closer to widespread adoption.”

Neuranics首席执行官Noel McKenna表示：“这项投资标志着我们继续在磁传感新应用领域开拓的重要一步。在投资者的支持下，我们正在扩大团队、推进技术发展，并使我们的解决方案更接近广泛采用。”

In December 2023, the company announced the launch of a new

2023年12月，该公司宣布推出新的产品。

magnetic sensor development kit

磁传感器开发套件

tailored to record and wirelessly transmit the heart’s magnetic activity via Bluetooth for continuous recording and analysis on various devices.

专为记录并通过蓝牙无线传输心脏磁活动而设计，可实现多种设备上的连续记录和分析。

Sign up for our daily news round-up!

注册获取我们的每日新闻汇总！

Give your business an edge with our leading industry insights.

利用我们领先的行业洞察，为您的业务提供优势。

Sign up

注册

Share

分享

Copy Link

复制链接

Share on X

分享到X

Share on Linkedin

分享到领英

Share on Facebook

分享到Facebook